Her symptoms were well-controlled with prednisolone and hydroxychloroquine. She presented with a history of shortness of breath, diffuse abdominal pain, and abdominal distension...The patient was treated initially with furosemide without improvement. After confirming the diagnosis, methylprednisolone and oral prednisone were then administered with a favorable prognosis...Early recognition is crucial to minimize the need for unnecessary invasive procedures. The goal is to initiate the appropriate management as early as possible to optimize patient outcomes.
The patient declined cytotoxic chemotherapy and was treated with oral methylprednisolone (40 mg/day), which was gradually tapered to 10 mg/day...This case highlights a rare presentation of iMCD with eosinophilia and pulmonary involvement, emphasizing the importance of early recognition and timely corticosteroid therapy. Our report adds to the limited data on iMCD with eosinophilia and may help inform future clinical management.
P4, N=146, Not yet recruiting, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine; Shanghai Ninth People's Hospital, Shanghai JiaoTong University
P2, N=0, Withdrawn, Tianjin Medical University General Hospital | N=75 --> 0 | Trial completion date: Dec 2025 --> Dec 2026 | Initiation date: Dec 2024 --> Sep 2025 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2025 --> Jun 2026
5 months ago
Enrollment change • Trial completion date • Trial initiation date • Trial withdrawal • Trial primary completion date
OP should be considered when new lesions appear in the lungs of lung cancer patients, and distinguished from infectious pneumonia, metastasis, or cancer progression. In this respect, pathological biopsy plays an important role in diagnosis. In our case, discontinuation of ceritinib and regular steroid administration were effective.
P=N/A, N=30, Active, not recruiting, Assiut University | Not yet recruiting --> Active, not recruiting | Trial completion date: Jun 2024 --> Nov 2025 | Trial primary completion date: Mar 2024 --> Sep 2025
9 months ago
Enrollment closed • Trial completion date • Trial primary completion date